US equities |
MU $1,072.41 ▼-1.43% NVDA $235.32 ▼-0.91% SNDK $1,643.20 ▼-2.91% PLTR $197.71 ▲+1.85% AMD $631.95 ▼-2.15% INTC $109.53 ▼-3.17% SPCX $163.46 ▼-2.47% META $719.81 ▼-0.21%
FinancialContent

Latest News about Matthias Liechti

Recent news which mentions Matthias Liechti

MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
Tickers MNMD
Tags Benzinga News Robert Barrow
From Benzinga
Antidepressants Can Be Used During Psilocybin Treatment, A New MindMed & Liechti Lab Study Finds
Tickers MNMD
Tags Penny Stocks Study Education
From Benzinga